• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button Iconpurdue pharma

purdue pharma

FinanceAll 50 states agree to OxyContin maker Purdue Pharma’s plan for Sackler family to pay up to $7 billion to settle opioid epidemic lawsuits
By Geoff Mulvihill and The Associated PressJune 18, 2025
FinancePurdue Pharma makes new offer to settle lawsuits over Oxycontin opioid crisis, and it includes up to $7 billion cash from the Sacklers
By Geoff Mulvihill and The Associated PressMarch 19, 2025
HealthPurdue Pharma and Sackler family to pay $7.4 billion in revised settlement of lawsuits over OxyContin opioid toll
By Geoff Mulvihill and The Associated PressJanuary 24, 2025
A person stands outside of the Supreme Court holding a sign which reads "The Sacklers destroyed my parent's lives."
PoliticsThe Supreme Court just rejected a deal with the maker of OxyContin that would have shielded the billionaire Sackler family from liability—but provided billions of dollars to fight opioids
By The Associated Press and Mark ShermanJune 27, 2024
FinanceSupreme Court justices agonize over Purdue Pharma settlement that would let Sackler family walk away with billions: ‘There is no other deal’
By Mark Sherman and The Associated PressDecember 5, 2023
FinanceOxyContin-maker Purdue Pharma heads to Supreme Court in case over whether $6bn payoff can shield Sackler owners from future lawsuits
By Mark Sherman and The Associated PressDecember 4, 2023
People from across the United States, who lost loved ones due to the opioid epidemic, rallied at the Department of Justice in Washington DC, calling on Attorney General Merrick Garland and Deputy AG Lisa Monaco to bring criminal charges against members of the Sackler family
FinanceOxyContin maker’s settlement faces Supreme Court scrutiny
By Geoff Mulvihill, Mark Sherman and The Associated PressNovember 23, 2023
HealthMcKinsey agrees to pay $230m to settle suits claiming it fueled the opioid epidemic by advising drugmakers like Purdue how to sell painkillers
By Joel Rosenblatt and BloombergSeptember 27, 2023
Supreme Court
LeadershipBiden’s DOJ doesn’t think the Sackler family should get released from opioid liability and the Supreme Court agrees—for now
By Mark Sherman and The Associated PressAugust 10, 2023
Demonstration against the Purdue pharmaceutical bankruptcy deal in White Plains, New York
HealthSackler family to pay fine of $4.5 billion as OxyContin maker Purdue Pharma is dissolved
By Jeff Mulvihill and The Associated PressSeptember 1, 2021
PoliticsThe Sackler family, creators of OxyContin, are trying to protect a dark, twisted empire
By Nicole GoodkindApril 23, 2021
FinanceOxycontin-maker Purdue looks for way out of bankruptcy with $10 billion plan
By Jeff Mulvihill and The Associated PressMarch 16, 2021
HealthPeople harmed by OxyContin have more time to file claims
By The Associated PressJune 3, 2020
HealthPurdue Pharma bankruptcy is now open to OxyContin-related personal injury claims
By Geoff Mulvihill and The Associated PressJanuary 24, 2020
OxyContin
HealthBankruptcy Judge Thrust into Spotlight in Purdue Pharma Case
By Geoff Mulvihill and The Associated PressDecember 25, 2019
1
  • 1
  • 2
  • 3
3
Most Popular
Success
Japanese companies are paying older workers to sit by a window and do nothing—while Western CEOs demand super-AI productivity just to keep your jobAn image of a popular article
By Orianna Rosa RoyleFebruary 27, 2026
AI
The week the AI scare turned real and America realized maybe it isn't ready for what's comingAn image of a popular article
By Nick LichtenbergFebruary 28, 2026
Middle East
Iran is now on 'death ground' amid existential threat from U.S. attacks and could 'go big' in retaliation, former NATO commander warnsAn image of a popular article
By Jason MaFebruary 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.